Pliva 334 and Pregnancy: Risks and Safety Information
Pliva 334 is a brand of levonorgestrel 1.5 mg (emergency contraceptive, "Plan B" type). It is not for use in established pregnancy.
Key Facts
- Mechanism: Delays/prevents ovulation; may impair fertilization/implantation. Does not disrupt established pregnancy.
- Pregnancy category: FDA Category X (older labeling) / Contraindicated in pregnancy (not because it causes harm, but because it's ineffective and unnecessary).
- Teratogenicity: No evidence of birth defects if inadvertently taken in early pregnancy. Large cohort studies show no increased risk.
- Ectopic pregnancy risk: Levonorgestrel EC failure may be associated with slightly higher ectopic rate; evaluate for abdominal pain + positive pregnancy test after use.
If Already Pregnant
- Do not take Pliva 334—it will not work and exposes fetus unnecessarily.
- Confirm pregnancy with test/ultrasound.
- Discuss options (continuation, adoption, abortion) with a healthcare provider.
Contraception After Use
Levonorgestrel EC does not provide ongoing protection. Start regular contraception immediately (progestin-only pill, implant, IUD, or combined hormonal after next menses). Use backup (condoms) for 7 days if starting hormonal method.
Pregnancy & Health - Related Articles
- Inconclusive Pregnancy Test: Causes and Next Steps
- Fetal Alcohol Syndrome Risk Persists Even If You Stop Drinking After Pregnancy Confirmation
- Magnesium Citrate and Pregnancy: Safety & Usage
- Umbilical Cord Care During Pregnancy: Why Not to Clean It
- Tummy Tuck (Abdominoplasty) and Future Pregnancy: Impact by Procedure Type
- Black Cohosh at 37 Weeks Pregnant: Unsafe—Risk of Preterm Labor
- Early Pregnancy Nausea: Normal vs. Hyperemesis Gravidarum
